John Elrod

John Elrod, PhD, is a Professor and Director of the Aging + Cardiovascular Discovery Center at the Lewis Katz School of Medicine, Temple University. He leads a research laboratory focused on mitochondrial calcium signaling and its role in heart disease, particularly myocardial infarction and heart failure. His work integrates molecular, genetic, and systems biology approaches to uncover novel therapeutic targets.

His research interests center on mitochondrial calcium exchange, genetic regulation of cell death, and metabolic dysfunction in cardiovascular disease. The Elrod lab utilizes genome-wide functional screening and genetically engineered mouse models to dissect the molecular mechanisms underlying necrosis and metabolic inflexibility in the heart. A major focus is on the mitochondrial permeability transition pore, the MCU complex, and NCLX-mediated calcium efflux.

His recent publications reveal a strong trend toward understanding the metabolic-epigenetic axis in cardiac remodeling, organelle dynamics in heart failure, and mitochondrial calcium as a central regulator of cell fate. His work spans from basic mechanisms to translational models, including large animal studies of HFpEF.

• Postdoctoral Fellow, Cincinnati Children's Medical Hospital, Howard Hughes Medical Institute (2012)
• PhD, Pathology, Albert Einstein College of Medicine (2007)
• BS, Biology (cum laude), Centenary College (2002)

Dr. Elrod has trained numerous researchers and collaborates extensively across disciplines. His lab has produced seminal work on hydrogen sulfide, nitric oxide, and mitochondrial calcium in cardioprotection. He has not received any explicitly listed scientific awards in the provided text, but his publication record in top-tier journals (Nature, PNAS, Circulation, Cell Metabolism) underscores significant recognition in the field.

He is actively involved in mentoring students and postdoctoral fellows, though specific names are not listed. His lab operates at the intersection of cardiac metabolism, mitochondrial dynamics, and fibrotic remodeling, with a clear focus on identifying druggable pathways for heart disease. The Aging + Cardiovascular Discovery Center serves as a hub for interdisciplinary research under his directorship.